References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
You should always stay well-hydrated when taking supplements, especially apple cider vinegar
Conclusion In the field of obesity, tirzepatide, although not yet approved by the FDA for weight loss, has superior clinical data to Wegovy (Figure 2)
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
However, Tesamorelin did not appear to improve pre-existing fibrosis significantly
Proposed Mechanisms DSIP appears to work through multiple pathways: it may affect GABA-A receptors, the same inhibitory pathways targeted by common sleep medications